IFNL3 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-IFNL3 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IFNL3 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 0.05 mL, 0.1 mL |
| Concentration | n/a |
| Applications | ELISA (EIA), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN-stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type-selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Seems not to be essential for early virus-activated host defense in vaginal infection, |
| Immunogen | Immunogen: Recombinant human Interferon lambda-3 protein (22-196aa) |
| Other Names | [IFN-lambda-3; Cytokine Zcyto22; Interleukin-28B; IL-28B; IL-28C; IFNL3; IL28B; IL28C; ZCYTO22], [IFNL3; IFNL3; IL28B; IL28C; IL-28B; IL28B; IL28C; ZCYTO22; IFN-lambda-3; IL-28B; IL-28C] |
| Gene, Accession # | [IFNL3], Gene ID: 282617, NCBI: NP_742151.2, UniProt: Q8IZI9 |
| Catalog # | MBS968924 |
| Price | $120, $160 |
| Order / More Info | IFNL3 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies